Elderly patients with chronic kidney disease: What is their course at one year?;Ancianos con enfermedad renal crónica: ¿cuál es su evolución al cabo de un año?

Nefrologia

Volumn 28, Issue 3, 2008, Pages 325-328

  Heras Benito, Manuel ^a   Fernandez Reyes Luis Ma J ^a   Sanchez Hernandez R ^a   Guerrero Diaz Ma T ^a   Munoz Pascual A ^a   Macias Ma C ^a   Molina, A ^a   Prado, F ^a   Alvarez Ude F ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Chronic kidney disease; Creatinine; Elderly; Filtrate glomerular estimate

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; PROSPECTIVE STUDY; TIME;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 51349165396     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Beck LH. Changes in renal function with aging. Clin Geriatr Med 1998; 14 (2): 199-209.
2. Mimran A. Renal function and aging. Nephrologie 1990; 11 (5): 275-80.
3. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Healt and Nutrition Examination Survey(1988-1994). Arch Intern Med 2002; 162: 1401-1408.
4. Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol 2006; 19 (5): 566-577.
5. Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis 2005; 45 (6): 978-993.
6. Kidney Disease Outcome Quality Inititative: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation , classification and stratification. Am J Kidney Dis 2002; 39: S76-S92.
7. Heras M, Guerrero MT, Sánchez R, Fernández-Reyes MJ, Muñoz A, Hernández V, Prado F, Álvarez-Ude F. Utilidad clínica de la creatinina plasmática como marcador de función renal y de riesgo cardiovascular en ancianos. Nefrología 2006; 26 Supl. (6): 58.
8. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
9. Levey AS, Greene T, Kusek JW, Beck GJ. Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 828 (A).
10. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E y cols. Progresion of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006; 69: 2155-2161.
11. O'Hare AM, Bertenthal D, Covinisky KE, Landefeld CS y cols. Mortality risk stratification in chronic kidney disease: one size for all ages. J Am Soc Nephrol 2006; 17: 846-853.
12. Derose S Crooks P, Rutkowski M, Levin N y cols. Age, GFR, and the risk of ESRD or death. ASN (Abstrac). J Am Soc Nephrol 2007; 18: 46A.
13. Eknoyan G. On epidemic cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes. Am J Kidney Disease 1998; 32: S1-S4.
14. Locatelli F, Pozzoni P. Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? Kidney Int 2006; 69 (12): 2155-2166.
15. Robles NR. Cálculo del filtrado glomerular: una visión escéptica. Nefrología 2007; 27 (4): 405-407.
16. Torregrosa I, Solis M, Pascual B y cols. Resultados preliminares de la implantación de un protocolo conjunto de manejo de la enfermedad renal crónica entre atención primaria y nefrología. Nefrología 2007; 27 (2): 162-167.
17. Documento de consenso sobre la Enfermedad renal crónica. SENsemFYC. www.senefro.org